Categories: Sports

First qualification systems for LA28 approved

10 December 2025 – The first set of qualification systems for the LA28 Olympic Games has been approved by the International Olympic Committee (IOC) Executive Board (EB), marking a key milestone on the road to the next edition of the Games.

- Advertisement -

Qualification systems for 26 sports and disciplines were presented and approved during today’s meeting in Lausanne, Switzerland, with the remaining systems to be submitted to the IOC EB in early 2026. All systems have been developed in line with the Qualification System Principles (QSP) approved by the IOC EB in March 2025.

- Advertisement -

Each International Federation (IF) is responsible for establishing its sports rules for participation in the Olympic Games, including qualification criteria in accordance with the Olympic Charter. Such criteria must be submitted to the IOC EB for approval.

- Advertisement -

For most of the sports and disciplines presented today, the systems are based on the successful, well-established pathways in place for Paris 2024 and previous Olympic Games. Recommendations from the Paris 2024 debrief process – conducted with National Olympic Committees (NOCs), IFs, the IOC and other stakeholders – have been applied where feasible.

- Advertisement -

The LA28 qualification systems ensure athletes have at least two opportunities to qualify, maintain continental and universal representation, and aim to minimise travel demands. This decision on the qualification systems for LA28 has been taken earlier by the IOC EB compared to previous editions of the Games, thus providing NOCs, athletes and entourage members with earlier visibility and longer timelines to prepare for their participation in the LA28 Olympic Games.

- Advertisement -

Click here to see all the approved qualification systems.

- Advertisement -
TheNewsMarketTeam

Recent Posts

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

3 days ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

1 week ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

1 week ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 month ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago

Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment

Basel, January 9, 2026 – Novartis, a leading global innovative medicines company, today announced plans…

1 month ago